Computational assessment of the effects of a pulsatile pump on toxin removal in blood purification.
BACKGROUND
For blood purification systems using a semipermeable membrane, the convective mass transfer by ultrafiltration plays an important role in toxin removal. The increase in the ultrafiltration rate can improve the toxin removal efficiency of the device, ultimately reducing treatment time and cost. In this study, we assessed the effects of pulsatile flow on the efficiency of the convective toxin removal in blood purification systems using theoretical methods.


METHODS
We devised a new mathematical lumped model to assess the toxin removal efficiency of blood purification systems in patients, integrating the mass transfer model for a human body with a dialyser. The human body model consists of a three-compartment model of body fluid dynamics and a two-compartment model of body solute kinetics. We simulated three types of blood purification therapy with the model, hemofiltration, hemodiafiltration, and high-flux dialysis, and compared the simulation results in terms of toxin (urea and beta-2 microglobulin) clearance and the treatment dose delivered under conditions of pulsatile and non-pulsatile pumping. In vivo experiments were also performed to verify the model results.


RESULTS
Simulation results revealed that pulsatile flow improved the convective clearance of the dialyser and delivered treatment dose for all three types of therapy. Compared with the non-pulsatile pumping method, the increases in the clearance of urea and beta-2 microglobulin with pulsatile pumping were highest with hemofiltration treatment (122.7% and 122.7%, respectively), followed by hemodiafiltration (3.6% and 8.3%, respectively), and high-flux dialysis (1.9% and 4.7%, respectively). EKRc and std Kt/V averaged 28% and 23% higher, respectively, in the pulsatile group than in the non-pulsatile group with hemofiltration treatment.


CONCLUSIONS
The pulsatile effect was highly advantageous for all of the toxins in the hemofiltration treatment and for beta2-microglobulin in the hemodiafiltration and high-flux dialysis treatments.
Lim
Ki Moo
KM
Department of Mechanical & Biomedical Engineering, Kangwon National University, Chuncheon, Kangwon-do, Republic of Korea.
Shim
Eun Bo
EB
D003198:Computer Simulation; D006801:Humans; D008954:Models, Biological; D011673:Pulsatile Flow; D017582:Renal Replacement Therapy / Q000379:methods*; D015203:Reproducibility of Results; D013997:Time Factors; D014508:Urea / Q000302:isolation & purification / Q000633:toxicity; D001613:beta 2-Microglobulin / Q000302:isolation & purification / Q000633:toxicity
D001613:beta 2-Microglobulin; D014508:Urea